{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T03:33:09Z","timestamp":1778643189673,"version":"3.51.4"},"reference-count":24,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Society of Cytopathology"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.jasc.2019.12.003","type":"journal-article","created":{"date-parts":[[2020,2,7]],"date-time":"2020-02-07T03:29:44Z","timestamp":1581046184000},"page":"146-151","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Utility of Claudin-4 versus BerEP4 and B72.3 in pleural fluids with metastatic lung adenocarcinoma"],"prefix":"10.1016","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5200-8560","authenticated-orcid":false,"given":"Ami","family":"Patel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alain C.","family":"Borczuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Momin T.","family":"Siddiqui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jasc.2019.12.003_bib1","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.lungcan.2018.11.020","article-title":"Measurement and immunophenotyping of pleural fluid EpCAM-positive cells and clusters for the management of non-small cell lung cancer patients","volume":"127","author":"Thompson","year":"2019","journal-title":"Lung Cancer"},{"key":"10.1016\/j.jasc.2019.12.003_bib2","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/dc.23659","article-title":"Pleural fluid cytology samples in cases of suspected lung cancer: an experience from a tertiary care centre","volume":"45","author":"Kaur","year":"2017","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.jasc.2019.12.003_bib3","series-title":"Koss\u2019 Diagnostic Cytology and its Histopathologic Bases","author":"Koss","year":"2006"},{"key":"10.1016\/j.jasc.2019.12.003_bib4","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/cncy.21392","article-title":"Claudin-4 immunohistochemistry is highly effective in distinguishing adenocarcinoma from malignant mesothelioma in effusion cytology","volume":"122","author":"Jo","year":"2014","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.jasc.2019.12.003_bib5","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/modpathol.3800544","article-title":"The diagnostic utility of immunohistochemistry in distinguishing between epithelioid mesotheliomas and squamous carcinomas of the lung: a comparative study","volume":"19","author":"Ord\u00f3\u00f1ez","year":"2006","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jasc.2019.12.003_bib6","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1097\/01.pai.0000213148.62525.9a","article-title":"Evidence-based guidelines for the utilization of immunostains in diagnostic pathology: pulmonary adenocarcinoma versus mesothelioma","volume":"15","author":"Marchevsky","year":"2007","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1016\/j.jasc.2019.12.003_bib7","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/dc.21380","article-title":"Usefulness of claudin 4 in the cytological diagnosis of serosal effusions","volume":"39","author":"Lonardi","year":"2011","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.jasc.2019.12.003_bib8","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/dc.23476","article-title":"Immunocytochemical utility of claudin-4 versus those of Ber-EP4 and MOC-31 in effusion cytology","volume":"44","author":"Oda","year":"2016","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.jasc.2019.12.003_bib9","doi-asserted-by":"crossref","first-page":"161","DOI":"10.4103\/2277-9175.138888","article-title":"Diagnostic value of claudin-4 marker in pleural and peritoneal effusion cytology: does it differentiate between metastatic adenocarcinoma and reactive mesothelial cells?","volume":"3","author":"Afshar-Moghaddam","year":"2014","journal-title":"Adv Biomed Res"},{"issue":"Suppl 8","key":"10.1016\/j.jasc.2019.12.003_bib10","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1002\/cncy.22021","article-title":"Ancillary studies in pleural, pericardial, and peritoneal effusion cytology","volume":"126","author":"Sundling","year":"2018","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.jasc.2019.12.003_bib11","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s00428-007-0448-x","article-title":"Claudin 4 identifies a wide spectrum of epithelial neoplasms and represents a very useful marker for carcinoma versus mesothelioma diagnosis in pleural and peritoneal biopsies and effusions","volume":"451","author":"Facchetti","year":"2007","journal-title":"Virchows Arch"},{"key":"10.1016\/j.jasc.2019.12.003_bib12","doi-asserted-by":"crossref","first-page":"89","DOI":"10.5858\/arpa.2017-0124-RA","article-title":"Guidelines for pathologic diagnosis of malignant mesothelioma: 2017 update of the Consensus Statement From the International Mesothelioma Interest Group","volume":"142","author":"Husain","year":"2018","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.jasc.2019.12.003_bib13","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1136\/jcp.2005.028589","article-title":"Claudins in differential diagnosis between mesothelioma and metastatic adenocarcinoma of the pleura","volume":"59","author":"Soini","year":"2006","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.jasc.2019.12.003_bib14","series-title":"Diagnostic Immunohistochemistry: Theranostic and Genomic Applications","author":"Monaco","year":"2019"},{"key":"10.1016\/j.jasc.2019.12.003_bib15","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1093\/ajcp\/109.1.85","article-title":"Value of the Ber-EP4 antibody in differentiating epithelial pleural mesothelioma from adenocarcinoma. The M.D. Anderson experience and a critical review of the literature","volume":"109","author":"Ord\u00f3\u00f1ez","year":"1998","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.jasc.2019.12.003_bib16","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1159\/000333982","article-title":"Ber-EP4 for differentiating adenocarcinoma from reactive and neoplastic mesothelial cells in serous effusions. Comparison with carcinoembryonic antigen, B72.3 and Leu-M1","volume":"40","author":"Bailey","year":"1996","journal-title":"Acta Cytol"},{"key":"10.1016\/j.jasc.2019.12.003_bib17","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/dc.2840090509","article-title":"Utility of BER-EP4 in the diagnosis of adenocarcinoma in effusions: an immunocytochemical study of 232 cases","volume":"9","author":"Diaz-Arias","year":"1993","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.jasc.2019.12.003_bib18","first-page":"33","article-title":"Diagnostic accuracy of a limited immuno-panel of calretinin and Ber-EP4 for diagnosis of malignant effusions","volume":"29","author":"Khurram","year":"2019","journal-title":"J Coll Phys Surg Pak"},{"key":"10.1016\/j.jasc.2019.12.003_bib19","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/dc.2840100207","article-title":"Monoclonal antibody Ber-EP4: its use in the differential diagnosis of malignant mesothelioma and carcinoma in cell blocks of malignant effusions and FNA specimens","volume":"10","author":"Maguire","year":"1994","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.jasc.2019.12.003_bib20","doi-asserted-by":"crossref","first-page":"e107741","DOI":"10.1371\/journal.pone.0107741","article-title":"Diagnostic accuracy of Ber-EP4 for metastatic adenocarcinoma in serous effusions: a meta-analysis","volume":"9","author":"Wang","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jasc.2019.12.003_bib21","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.anndiagpath.2015.03.007","article-title":"Claudin 3, 4, and 15 expression in solid tumors of lung adenocarcinoma versus malignant pleural mesothelioma","volume":"19","author":"Chaouche-Mazouni","year":"2015","journal-title":"Ann Diagn Pathol"},{"key":"10.1016\/j.jasc.2019.12.003_bib22","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/dc.2840110309","article-title":"Markers for metastatic adenocarcinoma in serous effusion specimens","volume":"11","author":"Shield","year":"1994","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.jasc.2019.12.003_bib23","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1309\/AJCP0B3YJBXWXJII","article-title":"Value of claudin-4 immunostaining in the diagnosis of mesothelioma","volume":"139","author":"Ord\u00f3\u00f1ez","year":"2013","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.jasc.2019.12.003_bib24","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/(SICI)1097-0339(199708)17:2<115::AID-DC6>3.0.CO;2-F","article-title":"Complementary value of five carcinoma markers for the diagnosis of malignant mesothelioma, adenocarcinoma metastasis, and reactive mesothelium in serous effusions","volume":"17","author":"Delahaye","year":"1997","journal-title":"Diagn Cytopathol"}],"updated-by":[{"DOI":"10.1016\/j.jasc.2020.09.011","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000}}],"container-title":["Journal of the American Society of Cytopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213294520300168?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213294520300168?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T06:46:19Z","timestamp":1761979579000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213294520300168"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S2213294520300168"],"URL":"https:\/\/doi.org\/10.1016\/j.jasc.2019.12.003","relation":{},"ISSN":["2213-2945"],"issn-type":[{"value":"2213-2945","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Utility of Claudin-4 versus BerEP4 and B72.3 in pleural fluids with metastatic lung adenocarcinoma","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Society of Cytopathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jasc.2019.12.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of American Society of Cytopathology.","name":"copyright","label":"Copyright"}]}}